Good conservative summary about ipilimumab, braf inhibitors and ckit inhibitors.

New and emerging approaches to the treatment of melanoma are described by Daniel G. Coit, MD, from Memorial Sloan-Kettering Cancer Center in this video from the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers dedicated to improving the quality and effectiveness of care for cancer patients. For more information on melanoma and other cancers, including the NCCN Guidelines for Patients, visit

Melanoma Research Foundation

Donate Today

Every day the Melanoma Research Foundation works to make the fight against melanoma easier.
Your donation will help us support patients, fund research and advocate for the melanoma community.